Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey
Abstract Introduction Myeloid Sarcoma (MS) is a rare hematologic myeloid neoplasm that
can involve any site of the body. It can occur as an exclusively extramedullary form or it can …
can involve any site of the body. It can occur as an exclusively extramedullary form or it can …
Characteristics and transplant outcome of myeloid sarcoma: a single-institute study
M Shan, Y Lu, M Yang, P Wang, S Lu, L Zhang… - International Journal of …, 2021 - Springer
We performed a retrospective study describing the characteristics of myeloid sarcoma (MS)
and evaluated the outcome of hematopoietic stem cell transplantation (HSCT) in patients …
and evaluated the outcome of hematopoietic stem cell transplantation (HSCT) in patients …
Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution
M Breccia, F Mandelli, MC Petti, M D'Andrea… - Leukemia research, 2004 - Elsevier
The aim of this study was to describe the presenting features, the frequency and outcome of
myeloid sarcoma (MS) diagnosed in our Institution from January 1995 to December 2000 …
myeloid sarcoma (MS) diagnosed in our Institution from January 1995 to December 2000 …
Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years
Background: Myeloid sarcoma (MS) is characterized by extramedullary infiltration by
immature myeloid cells. Owing to rarity of this disease, the clinical features and overall …
immature myeloid cells. Owing to rarity of this disease, the clinical features and overall …
Myeloid sarcoma: current approach and therapeutic options
B Avni, M Koren-Michowitz - Therapeutic Advances in …, 2011 - journals.sagepub.com
Myeloid sarcoma is a rare disease that can present as an isolated extramedullary leukemic
tumor, concurrently with or at relapse of acute myeloid leukemia. Owing to the rarity of this …
tumor, concurrently with or at relapse of acute myeloid leukemia. Owing to the rarity of this …
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC
P Chevallier, M Mohty, B Lioure, G Michel… - Journal of Clinical …, 2008 - ascopubs.org
Purpose This retrospective multicenter study assessed the outcome of 51 patients with
myeloid sarcoma (MS) who underwent allogeneic hematopoietic stem-cell transplantation …
myeloid sarcoma (MS) who underwent allogeneic hematopoietic stem-cell transplantation …
[HTML][HTML] Myeloid sarcomas: a clinicopathologic study of 20 cases
G Kaygusuz, D Kankaya, C Ekinci, P Topçuoğlu, I Kuzu - 2015 - jag.journalagent.com
Objective: Myeloid sarcoma is a tumoral mass of mature or immature myeloid blasts in
extramedullary anatomic locations. It can be seen de novo or in association with acute …
extramedullary anatomic locations. It can be seen de novo or in association with acute …
Is there a “gold” standard treatment for patients with isolated myeloid sarcoma?
D Antic, I Elezovic, N Milic, N Suvajdzic… - Biomedicine & …, 2013 - Elsevier
Isolated myeloid sarcoma is an extramedullary tumor of immature myeloid cells defined by
the absence of leukemia history, myelodisplastic syndrome, or myeloproliferative neoplasma …
the absence of leukemia history, myelodisplastic syndrome, or myeloproliferative neoplasma …
[HTML][HTML] Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
JY Lee, H Chung, H Cho, JE Jang, Y Kim… - Blood …, 2017 - synapse.koreamed.org
Background Isolated myeloid sarcoma (MS) is a rare extramedullary tumor mass composed
of malignant myeloid precursor cells without any evidence of leukemia in the peripheral …
of malignant myeloid precursor cells without any evidence of leukemia in the peripheral …
Differential diagnosis of isolated myeloid sarcoma: a case report and review of the literature
PA Hagen, C Singh, M Hart, AH Blaes - Hematology reports, 2015 - mdpi.com
Myeloid sarcoma (MS) is a rare disease entity identified as a variety of manifestations
defined by the occurrence of extramedullary myeloid cell masses with or without bone …
defined by the occurrence of extramedullary myeloid cell masses with or without bone …